Rebamipide mofetil
CAS No. 1527495-76-6
Rebamipide mofetil ( —— )
Catalog No. M28710 CAS No. 1527495-76-6
Rebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 79 | Get Quote |
|
5MG | 132 | Get Quote |
|
10MG | 205 | Get Quote |
|
25MG | 385 | Get Quote |
|
50MG | 575 | Get Quote |
|
100MG | 801 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRebamipide mofetil
-
NoteResearch use only, not for human use.
-
Brief DescriptionRebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
-
DescriptionRebamipide mofetil is an orally active prodrug of Rebamipide which is a mucoprotective agent.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorNO Synthase;MAO;Tyrosinase;inflammation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1527495-76-6
-
Formula Weight483.9
-
Molecular FormulaC25H26ClN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C(CC(c(cccc1)c1N1)=CC1=O)NC(c(cc1)ccc1Cl)=O)OCCN1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang S, et al. Rapid discovery and identification of anti-inflammatory constituents from traditional Chinese medicine formula by activity index, LC-MS, and NMR. Sci Rep. 2016 Aug 8;6:31000.
molnova catalog
related products
-
Oxaprozin
Oxaprozin is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID) used to relieve the inflammation, swelling, stiffness, and joint pain associated with osteoarthritis and rheumatoid arthritis.
-
Sulfasalazine
Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.
-
Ketorolac
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives. It acts by inhibiting the bodily synthesis of prostaglandins.